- Estée Lauder is a global manufacturer of luxury cosmetics, fragrances and skincare products, known for brands such as Estée Lauder, MAC, Clinique and La Mer, which are icons of the beauty industry.
- Estée Lauder is a global manufacturer of luxury cosmetics, fragrances and skincare products, known for brands such as Estée Lauder, MAC, Clinique and La Mer, which are icons of the beauty industry.
Estée Lauder’s (EL.US) shares are clearly gaining today after Goldman Sachs upgraded its recommendation from “Neutral” to “Buy” and raised the target price from $76 to $115, reflecting growing optimism about the company’s prospects. Estée Lauder is a well-known global producer of cosmetics, perfumes, and skincare products, with brands like Estée Lauder, MAC, Clinique, and La Mer considered flagship icons in the beauty industry.
Goldman Sachs' new rating reflects improved sales dynamics in the Chinese mainland, where after previous declines, average single-digit increases and a recovery in market shares are now observed in the second half of the fiscal year. Hainan's return to growth and improved inventory levels across the tourism channel were also an important catalyst, which reduced pressure on inventories.
The Investment Bank additionally emphasizes the improving trends of Estée Lauder's market shares also in the USA and the positive impact of the Management Board's actions on the conversion of growing traffic and operational efficiency. The expected expansion of the EBIT margin by approx. 500 basis points by 2028 and a slower than expected rate of decline in sales are building positive investor sentiment. Estée Lauder is also investing in geographical reorganization, channel diversification (e.g. Amazon) and brand development, which allows it to respond more effectively to changes in key markets. Thanks to this, the company presents itself as a beneficiary of the recovery in the Chinese market and effective corrective actions, which investors today translate into an increase in the valuation of shares.
The stock is extending its most dynamic rebound since 2022, as seen above its 50-week EMA. Source: xStation
Michelin cuts its 2025 forecasts, shares plunge!
EasyJet volatility spikes after takeover rumors 💡
US OPEN: "Green" Start to the Week on Wall Street
OpenAI Announces Partnership with Broadcom. Company Shares Soar!
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
